KKR, a leading global investment firm, and Avisena Healthcare, a Malaysian healthcare provider, have announced that funds managed by KKR have entered into a definitive agreement to make a minority investment in Avisena.
The investment will support Avisena’s next phase of growth, including the expansion of multi-specialty offerings at Avisena’s flagship hospitals in Shah Alam, and the build-out of new greenfield hospitals within the Klang Valley.
Founded in 1996, Avisena has built a leading healthcare presence in Shah Alam and the wider Klang Valley, Malaysia, where it operates Avisena Specialist Hospital and Avisena Specialist Hospital 2. Malaysia’s private healthcare market is experiencing growing demand, with capacity growth lagging demand in key urban areas.
SJ Lim, Managing Director at KKR, said, “Avisena has built a differentiated healthcare platform serving the community for over 30 years, anchored by a strong commitment to delivering quality, accessible patient care. We look forward to contributing towards building the business and working together with the Avisena team.”
Since 2004, KKR has invested more than $20 billion across the global healthcare ecosystem, working with healthcare businesses to support investment in clinical capabilities, technology and infrastructure and to expand access to high-quality care. Across Asia Pacific, KKR’s healthcare portfolio includes Medical Saigon Group in Vietnam and Metro Pacific Hospital Holdings, Inc. in the Philippines, and investments in healthcare businesses in India, Japan and China.
In Malaysia, KKR’s investments have included OMS Group, Weststar Aviation, and Taylor’s Schools, reflecting its approach of being an engaged, value-added strategic partner alongside founders and management teams.
